Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kenneth Williams, Susan Westmoreland, Jane Greco, Eva Ratai, Margaret Lentz, Woong-Ki Kim, Robert A. Fuller, John P. Kim, Patrick Autissier, Prahbat K. Sehgal, Raymond F. Schinazi, Norbert Bischofberger, Michael Piatak Jr., Jeffrey D. Lifson, Eliezer Masliah, R. Gilberto González
Published in Volume 115, Issue 9
J Clin Invest. 2005; 115(9):2534–2545 doi:10.1172/JCI22953
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

Plasma virus and monocyte-associated SIV RNA and DNA in SIV-infected, CD8 lymphocyte–depleted animals with and without CART. Comparisons were made between SIV-infected, CD8 lymphocyte–depleted animals with (open symbols) and without (filled symbols) CART. Quantitative, real-time PCR analysis demonstrated a decrease in SIV RNA in plasma and cell-associated SIV RNA and DNA in animals that received CART (A). Plasma virion RNA decreased 100- to 1,000-fold following CART that was initiated on day 28 after infection (arrow). (B) The level of monocyte-associated SIV RNA in the total blood monocyte population was decreased in CART-treated animals, which paralleled changes in plasma RNA. (C) The level of monocyte-associated SIV DNA decreased following CART, similar to decreases in plasma and cell-associated RNA levels.